1.
Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2. J of Skin [Internet]. 2019 Nov. 9 [cited 2025 Apr. 19];3:S40. Available from: https://skin.dermsquared.com/skin/article/view/767